Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Teladoc Health, Inc. (TDOC) had Revenue of $2.60B for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$2.60B
Net Income	$-220.37M
Cost of Goods Sold	$760.03M
Gross Profit	$1.84B
Operating Expenses	$2.85B
Operating Income	$-248.55M
Non-Operating Income/Expense	$28.95M
Pre-Tax Income	$-219.61M
Normalized Pre-Tax Income	$-219.61M
Income after Taxes	$-220.37M
Income from Continuous Operations	$-220.37M
Consolidated Net Income/Loss	$-220.37M
Normalized Income after Taxes	$-220.37M
EBIT	$-248.55M
EBITDA	$106.17M
Weighted-Average Shares Outstanding (Basic)	164.58M
Weighted-Average Shares Outstanding (Diluted)	164.58M
Earnings per Share (EPS) (Basic)	$-1.34
Earnings per Share (EPS) (Diluted)	$-1.34
Balance Sheet Financials
Current Assets	$1.49B
Property, Plant, and Equipment	$32.03M
Long-Term Assets	$2.90B
Total Assets	$4.39B
Current Liabilities	$420.62M
Long-Term Debt	$1.54B
Long-Term Liabilities	$1.65B
Total Liabilities	$2.07B
Common Equity	$2.33B
Tangible Shareholders Equity	$-424.90M
Shareholders Equity	$2.33B
Common Shares Outstanding	166.66M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$350.02M
Cash Flow from Investing Activities	$-156.35M
Cash Flow from Financial Activities	$10.85M
Beginning Cash	$918.18M
End Cash	$1.12B
Increase/Decrease in Cash	$205.49M
Stock-Based Compensation	$201.55M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.54
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	0.66
Gross Margin	70.80%
Operating Margin	-9.55%
EBIT Margin	-9.55%
EBITDA Margin	4.08%
Pre-Tax Profit Margin	-8.44%
Profit Margin	-8.47%
Free Cash Flow	$193.67M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.59
Inventory Turnover	25.75
Receiveable Turnover	11.97
Days Sales in Receivables	30.49
Return on Equity	-9.47%
Return on Tangible Equity	51.86%
Return on Assets	-5.02%
Return on Investments	-5.70%
Book Value Per Share	$13.96
Free Cash Flow per Share	$1.18
Operating Cash Flow per Share	$2.13

Data from Zacks Investment Research, Inc.